Amneal Pharmaceuticals LLC.

In News

Amneal Agrees to Acquire Kashiv BioSciences to Create - GlobeNewswire

GlobeNewswire - Apr 22, 2026

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader - Business Wire

Business Wire - Apr 22, 2026

Amneal Pharmaceuticals Reports Positive Interim Data from Phase 4 ELEVATE-PD Study Demonstrating Benefits of CREXONT in Parkinson's Disease Patients - Quiver Quantitative

Quiver Quantitative - Jun 05, 2026

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance

Yahoo Finance - Feb 27, 2026

Amneal Pharmaceuticals Added to S&P SmallCap 600® Index - GlobeNewswire

GlobeNewswire - Jan 28, 2026

Amneal Pharmaceuticals acquires Kashiv BioSciences for up to $1.1 billion - PharmaLive

PharmaLive - Apr 22, 2026

Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01% - Yahoo Finance

Yahoo Finance - Sep 23, 2025

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution - GlobeNewswire

GlobeNewswire - Jun 04, 2026

Case Study: Jazz Pharmaceuticals v. Amneal Pharmaceuticals - Food and Drug Law Institute (FDLI)

Food and Drug Law Institute (FDLI) - Oct 10, 2018

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026 - GlobeNewswire

GlobeNewswire - Jun 01, 2026

Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals - Business Wire

Business Wire - Jan 12, 2021

Amneal to Participate in Upcoming Investor Conference - GlobeNewswire

GlobeNewswire - Mar 05, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment